Investing Profile

Daniel Wagner

InvestorVC
Senior Managing Director at Connecticut Innovations
Photo of Daniel Wagner, Managing Director at Connecticut Innovations

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
Connecticut Innovations Managing Director
$150K - $7.0M
$3.5M
17
$4M
CompanyStageDateRound SizeTotal Raised
Biorez
SeedSep 2020$4M
Series CMar 2018$2M
Series UnknownJan 2014$5M
$11M
Co-investors: Elon Boms
P2 Science
Series CJan 2020$12M
Series AApr 2014$1M
SeedMay 2013$650K
SeedMar 2013$200K
$14M
Tangen Biosciences
Series AJun 2019$9M
$9M
New Haven Pharmaceuticals
Series BOct 2014$12M
Series AOct 2012$6M
$18M
Arvinas
Series ASep 2013$15M
$140M
Co-investors: Tim Shannon (Canaan Partners), Kush Parmar (5am Ventures), Stephen Squinto (OrbiMed), Colleen Cuffaro (Canaan Partners), Martin Alexander Gershon (Endeavor Venture Funds), Liam Ratcliffe (Access Biotechnology), Andrew Levin (RA Capital), Jakob Loven (Nextech Invest)
Innovatient Solutions
Series AApr 2013$630K
Debt FinancingNov 2012$250K
Series AApr 2011$2M
$2.9M
Co-investors: Matthew Storeygard (Connecticut Innovations)
SAMI Health
Series UnknownOct 2012$750K
SeedFeb 2012$500K
$1.3M
RemoteReality
Series CDec 2011$1M
$1M
Co-investors: Patrick ONeill (Sway Ventures), Patrick O'Neill (Connecticut Innovations)